{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T17:02:45Z","timestamp":1790960565598,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100011789","name":"Department of Science and Technology of Jilin Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011789","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010211","name":"Education Department of Jilin Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010211","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.cbi.2019.108794","type":"journal-article","created":{"date-parts":[[2019,8,14]],"date-time":"2019-08-14T02:00:42Z","timestamp":1565748042000},"page":"108794","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":64,"special_numbering":"C","title":["Acanthoic acid modulates lipogenesis in nonalcoholic fatty liver disease via FXR\/LXRs-dependent manner"],"prefix":"10.1016","volume":"311","author":[{"given":"Xin","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen-Yu","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Qing","family":"Piao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Hua","family":"Lian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Shuang","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ge","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiu-Xiu","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Xing","family":"Nan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Ling","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2019.108794_bib1","doi-asserted-by":"crossref","first-page":"4480","DOI":"10.1111\/bph.14503","article-title":"Diethyldithiocarbamate, an anti-abuse drug, alleviates steatohepatitis and fibrosis in rodents through modulating lipid metabolism and oxidative stress","volume":"175","author":"Liu","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.cbi.2019.108794_bib2","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jhep.2018.09.014","article-title":"Burden of liver diseases in the world","volume":"70","author":"Asrani","year":"2019","journal-title":"J. Hepatol."},{"key":"10.1016\/j.cbi.2019.108794_bib3","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/1753-0407.12056","article-title":"Study Group of Liver and Metabolism, et al., Diagnosis and management of non-alcoholic fatty liver disease and related metabolic disorders: consensus statement from the Study Group of Liver and Metabolism, Chinese Society of Endocrinology","volume":"5","author":"Gao","year":"2013","journal-title":"J. Diabetes"},{"key":"10.1016\/j.cbi.2019.108794_bib4","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1751-2980.2010.00476.x","article-title":"Guidelines for the diagnosis and management of nonalcoholic fatty liver disease: update 2010","volume":"12","author":"Fan","year":"2011","journal-title":"J. Dig. Dis."},{"key":"10.1016\/j.cbi.2019.108794_bib5","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3350\/cmh.2013.19.4.325","article-title":"KASL clinical practice guidelines: management of nonalcoholic fatty liver disease","volume":"19","author":"Korean Association for the Study of the Liver (KASL)","year":"2013","journal-title":"Clin. Mol. Hepatol."},{"key":"10.1016\/j.cbi.2019.108794_bib6","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/jgh.13856","article-title":"The asia-pacific working party on non-alcoholic fatty liver disease guidelines 2017-Part 2: management and special groups","volume":"33","author":"Chitturi","year":"2018","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.cbi.2019.108794_bib7","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/jgh.13857","article-title":"Asia-pacific working party on non-alcoholic fatty liver disease guidelines 2017-Part 1: definition, risk factors and assessment","volume":"33","author":"Wong","year":"2018","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.cbi.2019.108794_bib8","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1111\/j.1440-1746.2007.05001.x","article-title":"Non-alcoholic fatty liver disease in the Asia-Pacific region: definitions and overview of proposed guidelines","volume":"22","author":"Chitturi","year":"2007","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.cbi.2019.108794_bib9","doi-asserted-by":"crossref","first-page":"210","DOI":"10.3350\/cmh.2013.19.3.210","article-title":"Nonalcoholic fatty liver disease: molecular mechanisms for the hepatic steatosis","volume":"19","author":"Koo","year":"2013","journal-title":"Clin. Mol. Hepatol."},{"key":"10.1016\/j.cbi.2019.108794_bib10","article-title":"Coordinated actions of FXR and LXR in metabolism: from pathogenesis to pharmacological targets for type 2 diabetes","volume":"2014","author":"Ding","year":"2014","journal-title":"Internet J. Endocrinol."},{"key":"10.1016\/j.cbi.2019.108794_bib11","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1126\/science.284.5418.1365","article-title":"Bile acids: natural ligands for an orphan nuclear receptor","volume":"284","author":"Parks","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.cbi.2019.108794_bib12","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1172\/JCI21025","article-title":"Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c","volume":"113","author":"Watanabe","year":"2004","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.cbi.2019.108794_bib13","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1210\/me.2002-0120","article-title":"Bile acids induce the expression of the human peroxisome proliferator-activated receptor \u03b1 gene via activation of the farnesoid X receptor","volume":"17","author":"Torra","year":"2003","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.cbi.2019.108794_bib14","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1053\/j.gastro.2012.01.007","article-title":"Farnesoid X receptor protects hepatocytes from injury by repressing miR-199a-3p, which increases levels of LKB1","volume":"142","author":"Lee","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cbi.2019.108794_bib15","doi-asserted-by":"crossref","DOI":"10.1186\/1743-7075-3-31","article-title":"AICAR inhibits adipocyte differentiation in 3T3L1 and restores metabolic alterations in diet-induced obesity mice model","volume":"3","author":"Giri","year":"2006","journal-title":"Nutr. Metab."},{"key":"10.1016\/j.cbi.2019.108794_bib16","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.cmet.2009.02.006","article-title":"Hepatocyte-specific deletion of SIRT1 alters fatty acid metabolism and results in hepatic steatosis and inflammation","volume":"9","author":"Purushotham","year":"2009","journal-title":"Cell Metabol."},{"key":"10.1016\/j.cbi.2019.108794_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19061777","article-title":"Nuclear receptor regulation of aquaglyceroporins in metabolic organs","volume":"19","author":"Tardelli","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cbi.2019.108794_bib18","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.1101\/gad.844900","article-title":"Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXR\u03b1 and LXR\u03b2","volume":"14","author":"Repa","year":"2000","journal-title":"Genes Dev."},{"key":"10.1016\/j.cbi.2019.108794_bib19","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.phymed.2009.07.011","article-title":"Acanthoic acid, a diterpene in Acanthopanax koreanum, protects acetaminophen-induced hepatic toxicity in mice","volume":"17","author":"Wu","year":"2010","journal-title":"Phytomedicine"},{"key":"10.1016\/j.cbi.2019.108794_bib20","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.cbi.2014.04.016","article-title":"Acanthoic acid, a diterpene in Acanthopanax koreanum, ameliorates the development of liver fibrosis via LXRs signals","volume":"218","author":"Bai","year":"2014","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2019.108794_bib21","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s12072-010-9202-6","article-title":"Effects of nuclear receptor FXR on the regulation of liver lipid metabolism in patients with non-alcoholic fatty liver disease","volume":"4","author":"Yang","year":"2010","journal-title":"Hepatol. Int."},{"key":"10.1016\/j.cbi.2019.108794_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2017.00134","article-title":"Acanthoic acid can partially prevent alcohol exposure-induced liver lipid deposition and inflammation","volume":"8","author":"Yao","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.cbi.2019.108794_bib23","doi-asserted-by":"crossref","first-page":"7023","DOI":"10.1021\/acs.jafc.8b01982","article-title":"Ginsenoside 25-OCH3-PPD promotes activity of LXRs to ameliorate P2X7R-mediated NLRP3 inflammasome in the development of hepatic fibrosis","volume":"66","author":"Han","year":"2018","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.cbi.2019.108794_bib24","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/cr.2010.13","article-title":"PPARs: diverse regulators in energy metabolism and metabolic diseases","volume":"20","author":"Wang","year":"2010","journal-title":"Cell Res."},{"key":"10.1016\/j.cbi.2019.108794_bib25","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.dsx.2014.09.015","article-title":"PPAR gamma gene-a review","volume":"9","author":"Janani","year":"2015","journal-title":"Diabetes Metab. Syndr."},{"key":"10.1016\/j.cbi.2019.108794_bib26","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1016\/j.bbadis.2017.08.004","article-title":"Ablation of systemic SIRT1 activity promotes nonalcoholic fatty liver disease by affecting liver-mesenteric adipose tissue fatty acid mobilization","volume":"1863","author":"Cheng","year":"2017","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Basis Dis."},{"key":"10.1016\/j.cbi.2019.108794_bib27","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1159\/000487728","article-title":"ShenFu preparation protects AML12 cells against palmitic acid-induced injury through inhibition of both JNK\/Nox4 and JNK\/NF\u03baB pathways","volume":"45","author":"Ji","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.cbi.2019.108794_bib28","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1007\/s10620-015-3977-1","article-title":"Animal models of nonalcoholic steatohepatitis: eat, delete, and inflame","volume":"61","author":"Ibrahim","year":"2016","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.cbi.2019.108794_bib29","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.jhep.2017.06.003","article-title":"New trends on obesity and NAFLD in Asia","volume":"67","author":"Fan","year":"2017","journal-title":"J. Hepatol."},{"key":"10.1016\/j.cbi.2019.108794_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/nu10070830","article-title":"Antiobesity effects of ginsenoside Rg1 on 3t3-L1 preadipocytes and high fat diet-induced obese mice mediated by AMPK","volume":"10","author":"Liu","year":"2018","journal-title":"Nutrients"},{"key":"10.1016\/j.cbi.2019.108794_bib31","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-26701-0","article-title":"Glucose challenge metabolomics implicates medium-chain acylcarnitines in insulin resistance","volume":"8","author":"Nowak","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cbi.2019.108794_bib32","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cbi.2018.04.001","article-title":"3-Chloro-4,5-dihydroxybenzaldehyde inhibits adipogenesis in 3T3-L1 adipocytes by regulating expression of adipogenic transcription factors and AMPK activation","volume":"287","author":"Kang","year":"2018","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2019.108794_bib33","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.pharmthera.2017.05.011","article-title":"Targeting nuclear receptors for the treatment of fatty liver disease","volume":"179","author":"Tanaka","year":"2017","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.cbi.2019.108794_bib34","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.bbagrm.2016.03.002","article-title":"Nuclear receptors and nonalcoholic fatty liver disease","volume":"1859","author":"Cave","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.cbi.2019.108794_bib35","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.jhep.2013.01.006","article-title":"Essential fatty acids deficiency promotes lipogenic gene expression and hepatic steatosis through the liver X receptor","volume":"58","author":"Ducheix","year":"2013","journal-title":"J. Hepatol."},{"key":"10.1016\/j.cbi.2019.108794_bib36","doi-asserted-by":"crossref","first-page":"20015","DOI":"10.1074\/jbc.M802187200","article-title":"SIRT1 regulates hepatocyte lipid metabolism through activating AMP-activated protein kinase","volume":"283","author":"Hou","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cbi.2019.108794_bib37","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.3390\/nu9101086","article-title":"Silibinin restores NAD+ levels and induces the SIRT1\/AMPK pathway in non-alcoholic fatty liver","volume":"9","author":"Salomone","year":"2017","journal-title":"Nutrients"},{"key":"10.1016\/j.cbi.2019.108794_bib38","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.jhep.2013.12.012","article-title":"Cardiotrophin-1 eliminates hepatic steatosis in obese mice by mechanisms involving AMPK activation","volume":"60","author":"Casta\u00f1o","year":"2014","journal-title":"J. Hepatol."},{"key":"10.1016\/j.cbi.2019.108794_bib39","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.jhep.2014.10.039","article-title":"Molecular mechanism of PPAR\u03b1 action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease","volume":"62","author":"Pawlak","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.cbi.2019.108794_bib40","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.toxlet.2017.09.020","article-title":"Acanthoic acid protectsagainst ethanol-induced liver injury: possible role of AMPK activation and IRAK4 inhibition","volume":"281","author":"Yao","year":"2017","journal-title":"Toxicol. Lett."}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279719306404?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279719306404?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T13:56:09Z","timestamp":1757858169000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279719306404"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":40,"alternative-id":["S0009279719306404"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2019.108794","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acanthoic acid modulates lipogenesis in nonalcoholic fatty liver disease via FXR\/LXRs-dependent manner","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2019.108794","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108794"}}